Samuel Osiah Thier (born June 23, 1937)[1] was professor of Medicine and Health Care Policy at Harvard University.
Thier is an authority on internal medicine and kidney disease and is also known for his expertise in national health policy, medical education and biomedical research.
[4] In addition, he has received sixteen honorary degrees and the UC Medal of the University of California, San Francisco.
They agreed that Van Faasen would substantially increase insurance payments to Partners HealthCare doctors and hospitals, largely correcting the underpayments of the previous 10 years.
In 2007 he served as director of Merck & Company, the Charles River Laboratories, The Commonwealth Fund and the Federal Reserve Bank of Boston.